Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Guardado en:

Bibliografiske detaljer
Udgivet i:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Hovedforfatter:	Niazi, Sarfaraz K
Udgivet:	MDPI AG
Fag:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Online adgang:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Vær først til at give en kommentarø!